231 related articles for article (PubMed ID: 27238288)
21. Partial agonist activity of α1-adrenergic receptor antagonists for chemokine (C-X-C motif) receptor 4 and atypical chemokine receptor 3.
Gao X; Abdelkarim H; Albee LJ; Volkman BF; Gaponenko V; Majetschak M
PLoS One; 2018; 13(9):e0204041. PubMed ID: 30248140
[TBL] [Abstract][Full Text] [Related]
22. The atypical chemokine receptor ACKR3/CXCR7 is a broad-spectrum scavenger for opioid peptides.
Meyrath M; Szpakowska M; Zeiner J; Massotte L; Merz MP; Benkel T; Simon K; Ohnmacht J; Turner JD; Krüger R; Seutin V; Ollert M; Kostenis E; Chevigné A
Nat Commun; 2020 Jun; 11(1):3033. PubMed ID: 32561830
[TBL] [Abstract][Full Text] [Related]
23. Constitutive and chemokine-dependent internalization and recycling of CXCR7 in breast cancer cells to degrade chemokine ligands.
Luker KE; Steele JM; Mihalko LA; Ray P; Luker GD
Oncogene; 2010 Aug; 29(32):4599-610. PubMed ID: 20531309
[TBL] [Abstract][Full Text] [Related]
24. Atypical Chemokine Receptor 3 Generates Guidance Cues for CXCL12-Mediated Endothelial Cell Migration.
Tobia C; Chiodelli P; Barbieri A; Buraschi S; Ferrari E; Mitola S; Borsani G; Guerra J; Presta M
Front Immunol; 2019; 10():1092. PubMed ID: 31156639
[TBL] [Abstract][Full Text] [Related]
25. α
Albee LJ; Eby JM; Tripathi A; LaPorte HM; Gao X; Volkman BF; Gaponenko V; Majetschak M
J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28862946
[TBL] [Abstract][Full Text] [Related]
26. Emerging Roles of the Atypical Chemokine Receptor 3 (ACKR3) in Cardiovascular Diseases.
Duval V; Alayrac P; Silvestre JS; Levoye A
Front Endocrinol (Lausanne); 2022; 13():906586. PubMed ID: 35846294
[TBL] [Abstract][Full Text] [Related]
27. Functions of the CXCL12 Receptor ACKR3/CXCR7-What Has Been Perceived and What Has Been Overlooked.
Koch C; Engele J
Mol Pharmacol; 2020 Nov; 98(5):577-585. PubMed ID: 32883765
[TBL] [Abstract][Full Text] [Related]
28. The Kaposi's sarcoma-related herpesvirus (KSHV)-encoded chemokine vMIP-I is a specific agonist for the CC chemokine receptor (CCR)8.
Endres MJ; Garlisi CG; Xiao H; Shan L; Hedrick JA
J Exp Med; 1999 Jun; 189(12):1993-8. PubMed ID: 10377196
[TBL] [Abstract][Full Text] [Related]
29. New pairings and deorphanization among the atypical chemokine receptor family - physiological and clinical relevance.
Szpakowska M; D'Uonnolo G; Luís R; Alonso Bartolomé A; Thelen M; Legler DF; Chevigné A
Front Immunol; 2023; 14():1133394. PubMed ID: 37153591
[TBL] [Abstract][Full Text] [Related]
30. Stimulation of the atypical chemokine receptor 3 (ACKR3) by a small-molecule agonist attenuates fibrosis in a preclinical liver but not lung injury model.
Van Loy T; De Jonghe S; Castermans K; Dheedene W; Stoop R; Verschuren L; Versele M; Chaltin P; Luttun A; Schols D
Cell Mol Life Sci; 2022 May; 79(6):293. PubMed ID: 35562519
[TBL] [Abstract][Full Text] [Related]
31. Production of Chemokine/Chemokine Receptor Complexes for Structural Biophysical Studies.
Gustavsson M; Zheng Y; Handel TM
Methods Enzymol; 2016; 570():233-60. PubMed ID: 26921949
[TBL] [Abstract][Full Text] [Related]
32. Emerging roles of atypical chemokine receptor 3 (ACKR3) in normal development and physiology.
Quinn KE; Mackie DI; Caron KM
Cytokine; 2018 Sep; 109():17-23. PubMed ID: 29903572
[TBL] [Abstract][Full Text] [Related]
33. Kaposi's sarcoma-associated herpesvirus (KSHV) chemokine vMIP-II and human SDF-1alpha inhibit signaling by KSHV G protein-coupled receptor.
Geras-Raaka E; Varma A; Clark-Lewis I; Gershengorn MC
Biochem Biophys Res Commun; 1998 Dec; 253(3):725-7. PubMed ID: 9918794
[TBL] [Abstract][Full Text] [Related]
34. CXCR7 as a novel therapeutic target for advanced prostate cancer.
Gritsina G; Yu J
Oncogene; 2023 Mar; 42(11):785-792. PubMed ID: 36755058
[TBL] [Abstract][Full Text] [Related]
35. Atypical Chemokine Receptor 3 (ACKR3): A Comprehensive Overview of its Expression and Potential Roles in the Immune System.
Koenen J; Bachelerie F; Balabanian K; Schlecht-Louf G; Gallego C
Mol Pharmacol; 2019 Dec; 96(6):809-818. PubMed ID: 31040166
[TBL] [Abstract][Full Text] [Related]
36. Chemokine (C-X-C motif) receptor 4 and atypical chemokine receptor 3 regulate vascular α₁-adrenergic receptor function.
Bach HH; Wong YM; Tripathi A; Nevins AM; Gamelli RL; Volkman BF; Byron KL; Majetschak M
Mol Med; 2014 Oct; 20(1):435-47. PubMed ID: 25032954
[TBL] [Abstract][Full Text] [Related]
37. Molecular anatomy of CCR5 engagement by physiologic and viral chemokines and HIV-1 envelope glycoproteins: differences in primary structural requirements for RANTES, MIP-1 alpha, and vMIP-II Binding.
Navenot JM; Wang ZX; Trent JO; Murray JL; Hu QX; DeLeeuw L; Moore PS; Chang Y; Peiper SC
J Mol Biol; 2001 Nov; 313(5):1181-93. PubMed ID: 11700073
[TBL] [Abstract][Full Text] [Related]
38. Reassessing the adrenomedullin scavenging function of ACKR3 in lymphatic endothelial cells.
Sigmund EC; Bauer A; Jakobs BD; Tatliadim H; Tacconi C; Thelen M; Legler DF; Halin C
PLoS One; 2023; 18(5):e0285597. PubMed ID: 37252916
[TBL] [Abstract][Full Text] [Related]
39. A broad-spectrum chemokine antagonist encoded by Kaposi's sarcoma-associated herpesvirus.
Kledal TN; Rosenkilde MM; Coulin F; Simmons G; Johnsen AH; Alouani S; Power CA; Lüttichau HR; Gerstoft J; Clapham PR; Clark-Lewis I; Wells TN; Schwartz TW
Science; 1997 Sep; 277(5332):1656-9. PubMed ID: 9287217
[TBL] [Abstract][Full Text] [Related]
40. CXCR7 functions as a scavenger for CXCL12 and CXCL11.
Naumann U; Cameroni E; Pruenster M; Mahabaleshwar H; Raz E; Zerwes HG; Rot A; Thelen M
PLoS One; 2010 Feb; 5(2):e9175. PubMed ID: 20161793
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
